Recurrent urinary tract infection associated with SGLT-2 inhibitor in type 2 diabetes mellitus patient: A case report.

Mohammad HaziqueArihant SuranaMehul SinhaAyush Anand

Published in: Clinical case reports (2023)

A high index of clinical suspicion of urinary tract infections due to empagliflozin use should be maintained in T2DM patients to avoid progression to life-threatening condition.

Keyphrases

urinary tract infection
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors
case report
type diabetes
metabolic syndrome
weight loss
skeletal muscle
insulin resistance
patient reported